MARKETS
Analyst Actions

HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target

Oct 12, 2026 · 07:28 AM ET· updated 20h ago

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $14 price target.

Share
Why It Matters

An analyst still thinks Sophia Genetics is a good company to own. When experts keep believing in a stock, it shows steady confidence in the business.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.